Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long Term Safety of Fluticasone Furoate Nasal Spray in Perennial Allergic Rhinitis
NCT00224523Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2005
- Primary completion
- Feb 2007
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of fluticasone in perennial allergic rhinitis (PAR), sponsored by GSK. Started Sep 2005; status: completed.
02
Drugs
fluticasone
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00224523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00224523.